drugset / Trial / NCT03712423
PET Study With [89Zr]-Df-CriPec® Docetaxel
NaSingle-groupOpen-labelTreatment
Summary
A clinical phase I, open-label PET study with \[89Zr\]-Df-CriPec® docetaxel in patients with solid tumours to assess biodistribution and tumour accumulation of \[89Zr\]-Df-CriPec® docetaxel.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2020-03-25
- Completion
- 2020-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cripec Docetaxel | Unknown | — | — |